Serotonin (5-HT) in veins: Not all in vain

被引:28
|
作者
Linder, A. Elizabeth [1 ]
Ni, Wei [1 ]
Diaz, Jessica L. [1 ]
Szasz, Theodora [1 ]
Burnett, Robert [1 ]
Watts, Stephanie W. [1 ]
机构
[1] Michigan State Univ, Dept Pharmacol & Toxicol, E Lansing, MI 48824 USA
关键词
D O I
10.1124/jpet.107.122630
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The circulatory system consists of veins and arteries. Compared with arteries, veins have been neglected in cardiovascular research. Although veins are significantly less muscular than similarly sized arteries, the contribution of veins to cardiovascular homeostasis cannot be left un-noted because veins accommodate 70% of the circulating blood. Circulating blood platelets contain the majority of systemic 5- HT ( 5- hydroxytryptamine; serotonin). Similar to venous function, the physiological role of 5- HT in the cardiovascular system is not well understood. Here, we present not only a review on 5- HT and veins but ways in which these two topics might intersect in a physiologically relevant manner. Here we show the novel findings that veins exhibit higher amounts of intracellular 5- HT than arteries. Moreover, we also show evidence that, similar to arteries, veins have the ability to uptake 5- HT. In this review, we introduce the venous system as a reservoir for 5- HT in the periphery, suggesting that veins, in addition to arteries, may represent an important target for drugs that interfere with the serotonergic system. In addition, the serotonergic system from synthesis to metabolism, 5- HT receptor activation and venous diseases will also be discussed.
引用
收藏
页码:415 / 421
页数:7
相关论文
共 50 条
  • [21] Trazodone Acts as a Serotonin (5-HT) Reuptake Inhibitor and 5-HT1A Receptor Agonist on the 5-HT System
    Ghanbari, Ramez
    El Mansari, Mostafa
    Blier, Pierre
    BIOLOGICAL PSYCHIATRY, 2010, 67 (09) : 242S - 242S
  • [22] 5-HT1B RECEPTOR REGULATION OF SEROTONIN (5-HT) RELEASE BY ENDOGENOUS 5-HT IN THE SUBSTANTIA NIGRA
    Threlfell, S.
    Greenfield, S. A.
    Cragg, S. J.
    NEUROSCIENCE, 2010, 165 (01) : 212 - 220
  • [23] Animal models for studying serotonin (5-HT) receptor subtypes: Relationship to 5-HT system pathologies
    Ogren, SO
    Misane, I
    NUCLEAR MEDICINE AND BIOLOGY, 1998, 25 (08) : 747 - 749
  • [24] Serotonin (5-HT) Transporter Ligands Affect Plasma 5-HT in Rats Implications for Medication Development
    Rothman, Richard B.
    Zolkowska, Dorota
    Baumann, Michael H.
    DRUG ADDICTION: RESEARCH FRONTIERS AND TREATMENT ADVANCES, 2008, 1139 : 268 - 284
  • [25] Involvement of 5-HT2A Receptors in the Serotonin (5-HT) Syndrome caused by Excessive 5-HT Efflux in Rat Brain
    Krishnamoorthy, Swapna
    Ma, Zhiyuan
    Zhang, Gongliang
    Wei, Jianning
    Auerbach, Sidney B.
    Tao, Rui
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2010, 107 (04) : 830 - 841
  • [26] Renal interstitial serotonin (5-HT) and dopamine (DA)
    Berndt, TJ
    Liang, M
    Tyce, GM
    Knox, FG
    HYPERTENSION, 1999, 33 (04) : 1068 - 1068
  • [27] SPINAL SEROTONIN (5-HT) RECEPTOR SUBTYPES AND NOCICEPTION
    ZEMLAN, FP
    KOW, LM
    PFAFF, DW
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1983, 226 (02): : 477 - 485
  • [28] ROLE OF SEROTONIN (5-HT) IN PHASIC RELEASE OF GONADOTROPINS
    CHEN, HT
    SYLVESTER, PW
    IEIRI, T
    MEITES, J
    FEDERATION PROCEEDINGS, 1979, 38 (03) : 1107 - 1107
  • [29] EFFECT OF SEROTONIN (5-HT) ON INSULIN-SECRETION
    LECHIN, F
    COLLGARCIA, E
    VANDERDIJS, B
    PENA, F
    BENTOLILA, A
    RIVAS, C
    ACTA PHYSIOLOGICA LATINOAMERICANA, 1975, 25 (04) : 339 - 346
  • [30] MOLECULAR-BIOLOGY OF SEROTONIN (5-HT) RECEPTORS
    SHIH, JC
    YANG, W
    CHEN, K
    GALLAHER, T
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1991, 40 (04) : 1053 - 1058